AP9801417A0 - Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders. - Google Patents

Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders.

Info

Publication number
AP9801417A0
AP9801417A0 APAP/P/1998/001417A AP9801417A AP9801417A0 AP 9801417 A0 AP9801417 A0 AP 9801417A0 AP 9801417 A AP9801417 A AP 9801417A AP 9801417 A0 AP9801417 A0 AP 9801417A0
Authority
AP
ARIPO
Prior art keywords
treatment
acetic acid
thrombotic disorders
acid derivatives
piperidine acetic
Prior art date
Application number
APAP/P/1998/001417A
Other languages
English (en)
Inventor
David George Allen
Colin David Eldred
Brian David Judkins
William Leornard Mitchell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AP9801417A0 publication Critical patent/AP9801417A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/1998/001417A 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders. AP9801417A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
PCT/EP1997/003196 WO1997049699A1 (en) 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

Publications (1)

Publication Number Publication Date
AP9801417A0 true AP9801417A0 (en) 1998-12-31

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001417A AP9801417A0 (en) 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders.

Country Status (17)

Country Link
EP (1) EP0912555A1 (id)
JP (1) JP2000512648A (id)
KR (1) KR20000022041A (id)
AP (1) AP9801417A0 (id)
AR (1) AR008245A1 (id)
AU (1) AU3261197A (id)
BR (1) BR9709930A (id)
CA (1) CA2258753A1 (id)
CZ (1) CZ424698A3 (id)
EA (1) EA199801015A1 (id)
ID (1) ID17052A (id)
IL (1) IL127464A0 (id)
IS (1) IS4924A (id)
NO (1) NO985974L (id)
PL (1) PL330797A1 (id)
TR (1) TR199802665T2 (id)
WO (1) WO1997049699A1 (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
JP2004536113A (ja) 2001-07-03 2004-12-02 カイロン コーポレイション チロシンキナーゼおよびセリン／スレオニンキナーゼのインヒビターとしてのインダゾールベンズイミダゾール化合物
TW200401641A (en) * 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
CN100422171C (zh) * 2003-02-14 2008-10-01 惠氏公司 作为5-羟色胺-6配体的杂环-3-磺酰基吲唑
BRPI0709718A2 (pt) 2006-04-05 2011-03-29 Wyeth Corp composto; método para tratamento de um transtorno do sistema nervoso central relacionado a ou afetado pelo receptor 5-ht6 em um paciente necessitado; composição farmacêutica; e proceso para a preparação do composto
JP5208963B2 (ja) 2007-01-10 2013-06-12 エフ．ホフマン−ラ ロシュ アーゲー キマーゼ阻害剤としてのスルホンアミド誘導体
CN113655155A (zh) * 2021-07-28 2021-11-16 任贤金 一种测定sph3127有关物质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH07501063A (ja) * 1991-11-14 1995-02-02 グラクソ、グループ、リミテッド フィブリノーゲン依存性血小板凝集阻害剤としてのピペリジン酢酸誘導体
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
EP0912555A1 (en) 1999-05-06
NO985974D0 (no) 1998-12-18
JP2000512648A (ja) 2000-09-26
CZ424698A3 (cs) 1999-05-12
EA199801015A1 (ru) 1999-08-26
BR9709930A (pt) 1999-08-10
KR20000022041A (ko) 2000-04-25
IS4924A (is) 1998-12-15
NO985974L (no) 1999-02-17
IL127464A0 (en) 1999-10-28
AU3261197A (en) 1998-01-14
ID17052A (id) 1997-12-04
CA2258753A1 (en) 1997-12-31
PL330797A1 (en) 1999-06-07
TR199802665T2 (xx) 1999-03-22
AR008245A1 (es) 1999-12-29
WO1997049699A1 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
MY128654A (en) Liquid pharmaceutical composition containing an erythropoietin derivative
AU2267395A (en) Benzofuran derivatives useful as inhibitors of bone resorption
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
MY130157A (en) Method of use for inhibiting bone loss and lowering serum cholesterol
AU2002359164A1 (en) Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
AU2323897A (en) Cyclopropyl alkanoic acid derivatives
NZ505453A (en) Hypolipidemic benzothiazepine compounds
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
CA2260016A1 (en) Substituted pyridines as selective cyclooxygenase-2 inhibitors
HUP9603237A2 (hu) (R)-(-)-2-{N-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzizotiazol-2-il)-butil]-amino-metil}-kromán kristályos hidrokloridja, eljárás előállítására és a vegyületeket tartalmazó gyógyszerkészítmények
RU94038064A (ru) Производные пиперазина и пиперидина, их применение в качестве противопсихотических средств, способ их получения фармацевтическая композиция
HUP9802762A2 (hu) Difenil-metilén-piperidin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
AU5988086A (en) New carboxylic acid derivatives, processes for the preparation thereof, the use thereof and pharmaceutical compositions containing them
AU3563695A (en) Novel piperidine derivatives with paf antagonist activity
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
ATE259795T1 (de) Carbonsäuren und acylsulfonamide, solche verbindungen enthaltende zubereitungen und behandlungsmethoden
AU2002359162A1 (en) Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
AU1185801A (en) Novel compounds
CA2157792A1 (en) N-(3-piperidinyl-carbonyl)-beta-alanine derivatives as paf antagonists
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
NZ331256A (en) Benzo[c]quinolizine derivatives, their preparation and use as 5 alpha-reductases inhibitors
EP1446400A4 (en) Piperidin derivatives, process for their preparation and pharmaceutical composition for the treatment of Alzheimer's disease containing these derivatives
MXPA02005802A (es) Derivados heterociclicos.